Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2025

This bill would expand research and education on uterine fibroids, a common condition that can cause heavy bleeding, pain, anemia, and fertility problems for many people of reproductive age . It directs the health department to boost and coordinate research, with $30 million a year authorized from 2026 through 2030. It also creates or expands a database to track how Medicaid and CHIP cover fibroid treatments and requires a spending report to Congress within two years of enactment.

The bill starts public education efforts about who is at higher risk, especially minority communities, and shares information on the full range of treatment options, including alternatives to hysterectomy. It also asks medical groups and health systems to promote evidence-based care and inform providers about non-hysterectomy drugs and devices. Congress notes large health and cost impacts, racial disparities, and a lack of high-quality evidence for many treatments, underscoring the need for better data and care choices .

• Who is affected: People with uterine fibroids, especially minority individuals who face higher risks; health care providers; Medicaid and CHIP programs .
• What changes: More federal research; a Medicaid/CHIP treatment database and a spending report; public education on risks and options; provider guidance on evidence-based, non-hysterectomy treatments .
• When: Research funding and education efforts are authorized for fiscal years 2026–2030; the Medicaid/CHIP spending report is due within two years of enactment .